Testing protein markers in precancerous cervical lesions
Studies protein markers in tissue from precancerous changes of the cervix in adults.
Key facts
- Who runs it
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Where
- Bologna, ItalySee the site
- Trial code
- Registry title
- Evaluation of the Diagnostic and Prognostic Value of Immunohistochemical Markers in Precancerous Lesions of the Cervix
- Status
- Not yet recruiting
- People taking part
- 100 people, planned
- Started
- Feb 2025
- Planned end
- Feb 2026
- Type of study
- Interventional
- Treatments tested
- Tissue, diagnostic and prognostic accuracy
- Record updated
- 28 February 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 18 and over with a cervical precancer diagnosis (CIN/SIL) who had a cervical biopsy, and whose tissue sample is archived at the hospital pathology unit.
- Age
- 18 years and over
- Sex
- Women only
- Disease stage
- Precancerous cervical lesion (CIN/SIL) diagnosed on a cervical biopsy
Main reasons for not taking part
- No exclusion criteria are listed in the record
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Patients with a diagnosis of CIN/SIL undergoing cervical biopsy/concussion whose tissue sample is archived at the Operative Unit of Pathological Anatomy and Histology
- Obtaining written informed consent for the use of biological samples
- Patients aged 18 years and over
Where in Italy
- IRCCS Azienda Ospedaliero-Universitaria di BolognaBologna, ItalyContact: Paolo Casadio, MDNo longer taking part
About the trial
What the trial wants to find out
The study aims to evaluate the expression of certain proteins and their diagnostic and prognostic value in precancerous lesions of the cervix.
The group in the trial
- Patients diagnosed with precancerous lesions of the cervix CIN/SILOther group
Patients diagnosed with precancerous lesions of the cervix CIN/SIL undergoing diagnostic biopsy/uterine conization since January 2000
Treatment: Tissue, diagnostic and prognostic accuracy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluation Of The Diagnostic And Prognostic Value Of Immunohistochemical Markers In Precancerous Lesions Of The Cervix
- Plain-language title
- Testing protein markers in precancerous cervical lesionsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 28 February 2025